May 6, 2013 12:00 AM

Purdue Pharma continues to fight pain pill abuse

The Herald-Leader's editorial criticizes the Food and Drug Administration and Purdue Pharma for opposing the entry of generic copies of the original formulation of OxyContin® tablets after Purdue introduced a reformulated product designed to deter misuse and abuse of the medication.

Related content

Suggested for you



Editor's Choice Videos